2020
Artax Biopharma Appoints Joseph Lobacki as CEO
14/05/2020Autoimmune Disease Company Hires Life Science Industry Experts to Lead Company Through Next Stage into Human Clinical Studies with Novel Oral... Read More
The manufacturing challenge for AAV genetherapy
29/02/2020Editorial MedpageToday talks about Gene therapy and its challenges Read complete article here: https://www.medpagetoday.com/special-reports/exclusives/84956 Read More
Aura Biosciences presents updated clinical data for AU-011
25/02/2020Aura Biosciences presents updated phase 1b/2 clinical data for AU-011 at the 43rd Annual Macula Society Meeting Light-Activated AU-011 Holds Significant... Read More
Basque Country as the most attractive European region for foreign investment
24/02/2020The Financial Times ranks the Basque Country as the most attractive mid-sized European region for foreign direct investment strategy For the... Read More
Valuable in-kind donation from Viralgen for Gene Therapy research
20/02/2020Viralgen Vector Core, the leading GMP manufacturer of adeno associated virus, has recently donated a large in kind donation to Columbus... Read More
Quirónsalud treats the first patient with protontherapy in Spain
19/02/2020Quirónsalud treated the first patient in Spain with proton therapy at his Proton Therapy Center in Madrid https://www.quironsalud.es/es/comunicacion/notas-prensa/quironsalud-trata-primer-paciente-espana-terapia-protones Read More
First patient dosed in pivotal phase 3 trial of SNF472 in calciphylaxis
13/02/2020First patient dosed in phase 3 trial of SNF472 for the treatment of calcific uremic arteriolopathy (CUA) or calciphylaxis Palma,... Read More
Aura Biosciences Appoints George Golumbeski, Ph.D., as Chairman of the BOD
07/01/2020Aura Biosciences Appoints George Golumbeski, Ph.D., as Chairman of the Board of Directors CAMBRIDGE, Mass.-- Aura Biosciences, a clinical-stage biopharmaceutical... Read More